124 related articles for article (PubMed ID: 25982681)
1. Nuclear localization of MUC1 extracellular domain in breast, head and neck, and colon cancer.
Rabassa ME; Larrain MT; Lacunza E; Cermignani L; Alberdi CG; Demichelis SO; Abba MC; Segal-Eiras A; Croce MV
Int J Biol Markers; 2015 Jul; 30(3):e294-300. PubMed ID: 25982681
[TBL] [Abstract][Full Text] [Related]
2. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast.
Mommers EC; Leonhart AM; von Mensdorff-Pouilly S; Schol DJ; Hilgers J; Meijer CJ; Baak JP; van Diest PJ
Int J Cancer; 1999 Oct; 84(5):466-9. PubMed ID: 10502721
[TBL] [Abstract][Full Text] [Related]
4. Patterns of MUC1 tissue expression defined by an anti-MUC1 cytoplasmic tail monoclonal antibody in breast cancer.
Croce MV; Isla-Larrain MT; Rua CE; Rabassa ME; Gendler SJ; Segal-Eiras A
J Histochem Cytochem; 2003 Jun; 51(6):781-8. PubMed ID: 12754289
[TBL] [Abstract][Full Text] [Related]
5. MUC1 cytoplasmic tail detection using CT33 polyclonal and CT2 monoclonal antibodies in breast and colorectal tissue.
Croce MV; Isla-Larrain M; Remes-Lenicov F; Colussi AG; Lacunza E; Kim KC; Gendler SJ; Segal-Eiras A
Histol Histopathol; 2006 Aug; 21(8):849-55. PubMed ID: 16691537
[TBL] [Abstract][Full Text] [Related]
6. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
[No Abstract] [Full Text] [Related]
7. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.
Schroeder JA; Adriance MC; Thompson MC; Camenisch TD; Gendler SJ
Oncogene; 2003 Mar; 22(9):1324-32. PubMed ID: 12618757
[TBL] [Abstract][Full Text] [Related]
8. The MUC1 extracellular domain subunit is found in nuclear speckles and associates with spliceosomes.
Kumar P; Lindberg L; Thirkill TL; Ji JW; Martsching L; Douglas GC
PLoS One; 2012; 7(8):e42712. PubMed ID: 22905162
[TBL] [Abstract][Full Text] [Related]
9. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
[TBL] [Abstract][Full Text] [Related]
10. KL-6 is another useful marker in assessing a micropapillary pattern in carcinomas of the breast and urinary bladder, but not the colon.
Ohtsuki Y; Kuroda N; Umeoka T; Watanabe R; Ochi K; Okada Y; Lee GH; Furihata M
Med Mol Morphol; 2009 Jun; 42(2):123-7. PubMed ID: 19536620
[TBL] [Abstract][Full Text] [Related]
11. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
[TBL] [Abstract][Full Text] [Related]
12. Expression of tumour associated antigens in normal, benign and malignant human mammary epithelial tissue: a comparative immunohistochemical study.
Croce MV; Colussi AG; Price MR; Segal-Eiras A
Anticancer Res; 1997; 17(6D):4287-92. PubMed ID: 9494522
[TBL] [Abstract][Full Text] [Related]
13. Comparative immunohistochemical study of MUC1 and carbohydrate antigens in breast benign disease and normal mammary gland.
Demichelis SO; Alberdi CG; Servi WJ; Isla-Larrain MT; Segal-Eiras A; Croce MV
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):41-50. PubMed ID: 19625949
[TBL] [Abstract][Full Text] [Related]
14. Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.
Suzuki H; Shoda J; Kawamoto T; Shinozaki E; Miyahara N; Hotta S; Iizuka Y; Nakahara A; Tanaka N; Yanaka A; Irimura T
Clin Exp Metastasis; 2004; 21(4):321-9. PubMed ID: 15554388
[TBL] [Abstract][Full Text] [Related]
15. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature.
Rahn JJ; Dabbagh L; Pasdar M; Hugh JC
Cancer; 2001 Jun; 91(11):1973-82. PubMed ID: 11391575
[TBL] [Abstract][Full Text] [Related]
16. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Tumor-associated Mucin 1 Epitope Analyzed with the Humanized PankoMab-GEX™ Antibody in Malignant and Normal Tissues of the Head and Neck.
Wiest I; Alexiou C; Friese K; Betz P; Tübel J; Goletz S; Dian D; Jeschke U
Anticancer Res; 2016 Jun; 36(6):3179-84. PubMed ID: 27272845
[TBL] [Abstract][Full Text] [Related]
18. Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin.
Wen Y; Caffrey TC; Wheelock MJ; Johnson KR; Hollingsworth MA
J Biol Chem; 2003 Sep; 278(39):38029-39. PubMed ID: 12832415
[TBL] [Abstract][Full Text] [Related]
19. The cytoplasmic domain of MUC1 induces hyperplasia in the mammary gland and correlates with nuclear accumulation of β-catenin.
Li Y; Yi H; Yao Y; Liao X; Xie Y; Yang J; Yan Z; Wang L; Lu S; Kuang Y; Gu M; Fei J; Wang Z; Huang L
PLoS One; 2011 Apr; 6(4):e19102. PubMed ID: 21533058
[TBL] [Abstract][Full Text] [Related]
20. DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status.
Conde I; Alfaro JM; Fraile B; Ruíz A; Paniagua R; Arenas MI
Breast Cancer Res; 2004; 6(3):R140-8. PubMed ID: 15084237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
